Tag Archives: Adaptimmune Therapeutics

September, 2017

September, 2016

August, 2016

April, 2016

February, 2016

  • 2 February

    GSK and Adaptimmune Expand Immunotherapy Collaboration

    GlaxoSmithKline plc (LSE/NYSE: GSK) and Adaptimmune Therapeutics plc (Nasdaq: ADAP), a leader in the use of T-cell receptor (TCR) engineered T-cell therapy to treat cancer, today announced that the companies have expanded the terms of their strategic collaboration agreement to accelerate Adaptimmune’s lead clinical cancer programme, an affinity enhanced T-cell …